Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,455
Total Claims
$733K
Drug Cost
718
Beneficiaries
$1,021
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+4%
Opioid rate vs peers
2.3% vs 2.2% avg
-28%
Cost per patient vs peers
$1,021 vs $1,411 avg
-18%
Brand preference vs peers
8.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.3%
Opioid Rate
335
Opioid Claims
$15K
Opioid Cost
6.6%
Long-Acting Rate
Brand vs Generic
Brand: 1,248 claims · $457K
Generic: 13,124 claims · $270K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 245 | $149K |
| Rivaroxaban | 58 | $36K |
| Sitagliptin Phosphate | 42 | $25K |
| Linaclotide | 40 | $21K |
| Mirabegron | 26 | $15K |
| Empagliflozin | 23 | $14K |
| Insulin Aspart | 48 | $12K |
| Fluticasone/Vilanterol | 29 | $12K |
| Memantine Hcl | 205 | $12K |
| Budesonide/Formoterol Fumarate | 20 | $11K |
| Memantine Hcl | 119 | $10K |
| Insulin Glargine,hum.Rec.Anlog | 41 | $9,600 |
| Dapagliflozin Propanediol | 11 | $9,434 |
| Fluticasone/Umeclidin/Vilanter | 14 | $7,640 |
| Buprenorphine | 17 | $7,245 |
Prescribing Profile
Patient Profile
80
Avg Age
64%
Female
2.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About